- UroToday Home
- Recent Abstracts
- Urologic Oncology
Investigative Urology
p63 Cytoplasmic aberrance is associated with high prostate cancer stem cell expression - Abstract
November 1, 2012
Emerging putative biomarkers: The role of alpha 2 and 6 integrins in susceptibility, treatment, and prognosis - Abstract
October 31, 2012
Role of the HSP90-associated cochaperone p23 in enhancing activity of the androgen receptor and significance for prostate cancer - Abstract
October 31, 2012
Marked heterogeneity of ERG expression in large primary prostate cancers - Abstract
October 31, 2012
Role of C-reactive protein in urological cancers: A useful biomarker for predicting outcomes - Abstract
October 31, 2012
Does androgen-ablation therapy (AAT) associated autophagy have a pro-survival effect in LNCaP human prostate cancer cells? - Abstract
October 31, 2012
Interleukin-1α induces immunosuppression by mesenchymal stem cells promoting the growth of prostate cancer cells - Abstract
October 30, 2012
Arachidonic acid metabolism in human prostate cancer - Abstract
October 30, 2012
Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer - Abstract
October 30, 2012
The metabolic interactions between tumor cells and tumor-associated stroma (TAS) in prostatic cancer - Abstract
October 30, 2012
Targeting TCTP as a new therapeutic strategy in castration-resistant prostate cancer - Abstract
October 29, 2012
Galectin-3 expression in prostate cancer and benign prostate tissues: Correlation with biochemical recurrence - Abstract
October 29, 2012
The impact of cow's milk-mediated mTORC1- signaling in the initiation and progression of prostate cancer - Abstract
October 29, 2012
A comparison of Bayesian and frequentist approaches to incorporating external information for the prediction of prostate cancer risk - Abstract
October 29, 2012